Invention Application
- Patent Title: Novel compounds as pharmaceutical agents
- Patent Title (中): 新型化合物作为药剂
-
Application No.: US10535381Application Date: 2003-11-24
-
Publication No.: US20060058295A1Publication Date: 2006-03-16
- Inventor: Douglas Beight , Timothy Burkholder , Todd Decollo , Alexander Godfrey , Charles Heap , Chi-Hsin King , Hong-Yu Li , William McMillen , Jason Sawyer , Yan Wang , Clive Diefenbacher , Thomas Engler , Sushant Malhotra , Sreenivasa Mundla
- Applicant: Douglas Beight , Timothy Burkholder , Todd Decollo , Alexander Godfrey , Charles Heap , Chi-Hsin King , Hong-Yu Li , William McMillen , Jason Sawyer , Yan Wang , Clive Diefenbacher , Thomas Engler , Sushant Malhotra , Sreenivasa Mundla
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- International Application: PCT/US03/35969 WO 20031124
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/519 ; A61K31/4745 ; C07D471/02
Abstract:
The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
Public/Granted literature
- US07405299B2 Compounds as pharmaceutical agents Public/Granted day:2008-07-29
Information query
IPC分类:
